Trial intelligence / Profile preview

VI-0521 (Qsymia) Factorial Study in Obesity

NCT00563368Phase 3Completed

Sponsor
VIVUS
Start
Dec 2007
Primary completion
Sep 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of phentermine + topiramate in obesity, sponsored by VIVUS. Started Dec 2007; status: completed.

02

Drugs

phentermine + topiramate
03

Conditions

obesity

Beyond the preview

Go deeper on NCT00563368.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00563368.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call